Early research (Phase 1)Looking for participantsNCT07159126What this trial is testingDS3610a in Participants With Advanced Solid TumorWho this might be right forSolid TumorsMetastatic Solid Tumors Daiichi Sankyo 70
Not applicableStudy completedNCT01987726What this trial is testingComprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid TumorsWho this might be right forRecurrent Breast CancerRecurrent Colon CancerRecurrent Rectal Cancer+5 more Ohio State University Comprehensive Cancer Center 150
Large-scale testing (Phase 3)Looking for participantsNCT05760378What this trial is testingFamitinib in Combination With Camrelizumab and TPC in The First-line Treatment of Immunomodulatory Locally Advanced or Metastatic TNBC.Who this might be right forTriple-Negative Breast Cancer Fudan University 223
Early research (Phase 1)Study completedNCT03150810What this trial is testingStudy to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumors BeiGene 139
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05947825What this trial is testingSitagliptin Combined With Gemcitabine and Albumin-bound Paclitaxel in PDAC PatientsWho this might be right forPDAC - Pancreatic Ductal Adenocarcinoma Tianjin Medical University Cancer Institute and Hospital 30
Early research (Phase 1)WithdrawnNCT02569489What this trial is testingDose Escalation Study of HBI-8000 in Combination With Paclitaxel and Trastuzumab in Women With Advanced or Metastatic HER2+ Breast CancerWho this might be right forBreast Cancer HUYABIO International, LLC.
Post-approval studies (Phase 4)Ended earlyNCT00604968What this trial is testingPegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)Who this might be right forBreast Neoplasms Merck Sharp & Dohme LLC 25
Large-scale testing (Phase 3)Ended earlyNCT03326674What this trial is testingTesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBCWho this might be right forBreast Cancer Odonate Therapeutics, Inc. 685
Early research (Phase 1)Study completedNCT00532090What this trial is testingA Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors.Who this might be right forNeoplasms Hoffmann-La Roche 110
Early research (Phase 1)Not Yet RecruitingNCT07797907What this trial is testingThis Clinical Study is to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Antitumor Activity of BD200 in Participants With Advanced or Metastatic Cancer.Who this might be right forSolid Tumor (Phase I) Biolojic Design Ltd. 110
Testing effectiveness (Phase 2)Study completedNCT02428192What this trial is testingNivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine LeiomyosarcomaWho this might be right forMetastatic LeiomyosarcomaUnresectable LeiomyosarcomaUterine Corpus Leiomyosarcoma National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT05087992What this trial is testingFind the Best Dose of BI 905711 in Combination With Chemotherapy and to Test Whether This Dose Helps People With Advanced Gastrointestinal CancersWho this might be right forGastrointestinal Cancer, Metastatic Boehringer Ingelheim 13
Early research (Phase 1)Active Not RecruitingNCT04898634What this trial is testingJNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate CancerWho this might be right forProstatic Neoplasms Janssen Research & Development, LLC 216
Testing effectiveness (Phase 2)Ended earlyNCT00880009What this trial is testingStudy Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast CancerWho this might be right forBreast Cancer Pfizer 16
Large-scale testing (Phase 3)UnknownNCT00541021What this trial is testingGemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Institut Paoli-Calmettes 104
Testing effectiveness (Phase 2)Active Not RecruitingNCT04920708What this trial is testingFulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA SuppressionWho this might be right forMetastatic Breast CancerER+ Breast CancerAdvanced Breast Cancer Royal Marsden NHS Foundation Trust 57
Very early researchLooking for participantsNCT04005690What this trial is testingTargeted Pathway Inhibition in Patients With Pancreatic CancerWho this might be right forLocally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8+5 more OHSU Knight Cancer Institute 90
Large-scale testing (Phase 3)Study completedNCT00008060What this trial is testingCombination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal CancerWho this might be right forColorectal Cancer Medical Research Council
Testing effectiveness (Phase 2)Looking for participantsNCT06125080What this trial is testingThe Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ：Single-arm, Prospective, Open Clinical StudyWho this might be right forTNBC - Triple-Negative Breast Cancer Huihua Xiong 78
Large-scale testing (Phase 3)Active Not RecruitingNCT04975308What this trial is testingImlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast CancerWho this might be right forBreast NeoplasmsNeoplasm Metastasis Eli Lilly and Company 874